- Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice, Xiao-Wen Chen, Xiao-Yan Du, Yu-Xian Wang, Jian-Cheng Wang, Wen-Ting Liu, Wen-Jing Chen, Hong-Yu Li, Fen-Fen Peng, Zhao-Zhong Xu, Hong-Xin Niu, and Hai-Bo Long
Mediators of Inflammation
Research Article (10 pages), Article ID 1405924, Volume 2016 (2016)
Published 6 January 2016
Mediators of Inflammation
Volume 2016, Article ID 3151986, 2 pages
http://dx.doi.org/10.1155/2016/3151986
Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”
1Department of Nephrology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
2Department of Gerontology, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
3Department of Emergency, ZhuJiang Hospital, Southern Medical University, Guangzhou 510280, China
Received 8 June 2016; Accepted 15 August 2016
Copyright © 2016 Xiao-Wen Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
How to Cite this Article
Xiao-Wen Chen, Xiao-Yan Du, Yu-Xian Wang, et al., “Corrigendum to “Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice”,” Mediators of Inflammation, vol. 2016, Article ID 3151986, 2 pages, 2016. https://doi.org/10.1155/2016/3151986.